tiprankstipranks
Alexium International Group Limited (AU:AJX)
ASX:AJX
Want to see AU:AJX full AI Analyst Report?

Alexium International Group (AJX) AI Stock Analysis

7 Followers

Top Page

AU:AJX

Alexium International Group

(Sydney:AJX)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - Gpt-5.6Sol)
Rating:44Neutral
Price Target:
AU$0.01
▲(0.00% Upside)
Action:Upgraded
Date:09/06/26
The score is primarily driven by weak financial performance: widening losses, negative equity, and persistent cash burn outweigh the FY2026 revenue rebound. With no usable technical indicators and a negative P/E (loss-making) alongside no dividend yield data, valuation/market-signal support is limited, keeping the overall score low.
Positive Factors
FY2026 Revenue Rebound
The FY2026 revenue rebound indicates renewed commercial activity across Alexium’s specialty materials business after several years of declines. If customer adoption and processed-material volumes remain elevated, the improved top line could provide a base for operating leverage over the next several quarters.
Negative Factors
Widening Losses and Margin Pressure
The revenue rebound has not translated into stronger earnings power: gross margin contracted materially and net losses widened. Persistent negative margins weaken internal funding capacity and suggest that additional revenue growth may not produce durable profitability without better cost absorption or pricing.
Read all positive and negative factors
Positive Factors
Negative Factors
FY2026 Revenue Rebound
The FY2026 revenue rebound indicates renewed commercial activity across Alexium’s specialty materials business after several years of declines. If customer adoption and processed-material volumes remain elevated, the improved top line could provide a base for operating leverage over the next several quarters.
Read all positive factors

Alexium International Group (AJX) vs. iShares MSCI Australia ETF (EWA)

Alexium International Group Business Overview & Revenue Model

Company Description
Alexium International Group Limited is a U.S.-based firm specializing in the production and distribution of phase-change materials (PCM) and various advanced textile technologies. The company's portfolio includes a range of thermal management solu...
How the Company Makes Money
Alexium makes money primarily by selling its specialty chemistries and treatment solutions and by providing related application/processing services for customers who apply these technologies to fabrics or other substrates. Key revenue streams typi...

Alexium International Group Financial Statement Overview

Summary
Despite a sharp FY2026 revenue rebound (+106.96%), profitability remains very weak with materially lower gross margin (28.94% vs. 43.09%) and widening net losses (FY2026 net income -6.29M vs. -3.93M). The balance sheet remains high-risk due to negative equity in recent years (FY2026 equity -0.34M) even though total debt has declined (FY2023 4.69M to FY2026 1.32M). Cash flow is a major concern with consistently negative operating and free cash flow, worsening in FY2026 (OCF -3.33M; FCF -3.33M).
Income Statement
18
Very Negative
Balance Sheet
24
Negative
Cash Flow
16
Very Negative
BreakdownJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue4.24M3.92M5.89M7.19M8.14M
Gross Profit1.23M1.69M2.64M2.81M3.32M
EBITDA-2.71M-3.25M-962.00K-1.38M-1.54M
Net Income-6.29M-3.93M-2.76M-2.95M-3.36M
Balance Sheet
Total Assets2.34M2.88M5.23M5.37M6.40M
Cash, Cash Equivalents and Short-Term Investments217.24K662.45K2.05M511.78K1.02M
Total Debt1.32M2.55M969.43K4.69M3.85M
Total Liabilities2.68M3.28M1.93M6.35M4.83M
Stockholders Equity-343.49K-402.08K3.30M-980.26K1.57M
Cash Flow
Free Cash Flow-3.33M-2.80M-1.35M-1.49M-1.93M
Operating Cash Flow-3.33M-2.58M-1.19M-1.10M-1.57M
Investing Cash Flow-7.72K-218.09K-156.22K-385.41K-353.35K
Financing Cash Flow2.74M1.42M2.91M992.85K74.01K

Alexium International Group Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
50
Neutral
AU$33.37M-6.61-75.44%20.00%-3.10%39.78%
44
Neutral
AU$25.02M-1.80458.56%2.85%-13.89%
44
Neutral
AU$24.02M-7.97-113.85%-0.43%
44
Neutral
AU$55.09M-1.04-119.47%27.85%-141.00%
43
Neutral
AU$223.37M-5.49-74.68%-1.41%-4.04%
43
Neutral
AU$18.06M-1.37268.53%-74.92%-46.21%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:AJX
Alexium International Group
AU:TTT
Titomic Ltd
0.13
-0.13
-50.00%
AU:DTZ
Dotz Nano Limited
0.03
-0.03
-53.70%
AU:SPN
Sparc Technologies Ltd
0.18
0.03
20.00%
AU:CXL
Calix Ltd.
0.25
-0.16
-39.02%
AU:CG1
Carbonxt Group Ltd.
0.07
<0.01
7.46%

Alexium International Group Corporate Events

Alexium Files Updated Corporate Governance Statement With ASX
Aug 28, 2026
Alexium International Group Limited has lodged its corporate governance statement for the year ended 30 June 2026 with the ASX, confirming that the document is current as of 28 August 2026 and accessible via its investor relations website. The fil...
Alexium Releases 2026 Annual Report and Sets Investor Webinar
Aug 28, 2026
Alexium International Group Limited, a specialist provider of performance chemicals for advanced materials, focuses on flame retardancy and thermal management solutions across bedding, body armour, military uniforms and workwear. Its patent-protec...
Alexium Issues 4Q26 Results Briefing With Extensive Investor Disclaimers
Jul 31, 2026
Alexium International Group Limited, a specialty chemicals and advanced materials provider, reports its financial results in U.S. dollars to align with its operating and investor base. The company&#8217;s governance and disclosure practices follow...
Alexium Navigates Q4 Production Setback as mPCM and Flame-Resistant Coatings Strategy Advances
Jul 31, 2026
Alexium International Group reported a challenging fourth quarter of FY26 as manufacturing problems at its Dayton facility disrupted production and delayed an anticipated sales ramp-up following the Microtek Laboratories acquisition. While technol...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 06, 2026